Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia
Wissam K Kabbara,1 Wijdan H Ramadan,1 Peggy Rahbany,2 Souhaila Al-Natour3 1Department of Pharmacy Practice, School of Pharmacy, Lebanese American University, Byblos, Lebanon; 2Children’s National Medical Center, Washington, DC, USA; 3Medex Pharmaceutical Company, Beirut, Lebanon Background...
Saved in:
Main Authors: | Kabbara WK (Author), Ramadan WH (Author), Rahbany P (Author), Al-Natour S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic review of the prospective association of daily step counts with risk of mortality, cardiovascular disease, and dysglycemia
by: Katherine S. Hall, et al.
Published: (2020) -
Dysglycemia and dyslipidemia in Type 2 Diabetes Mellitus in co-morbidity with Hypothyroidism
by: Amrita Ghosh
Published: (2020) -
Pulmonary hypertension: diagnostic and therapeutic challenges
by: Bazan IS, et al.
Published: (2015) -
Diabetes in urban Guinea-Bissau; patient characteristics, mortality and prevalence of undiagnosed dysglycemia
by: Stine Byberg, et al.
Published: (2020) -
Optimizing clopidogrel dose response: a new clinical algorithm comprising CYP2C19 pharmacogenetics and drug interactions
by: Saab YB, et al.
Published: (2015)